LPL Financial’s Structure Therapeutics GPCR Stock Holding History

LPL Financial’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$584K	Buy	18,667 +4,334	+30%	+$203K	﹤0.01%	4985
2026 Q2	$769K	Buy	14,333 +5,073	+55%	+$224K	﹤0.01%	4648
2026 Q1	$446K	Buy	9,260 +1,151	+14%	+$78.8K	﹤0.01%	4864
2025 Q4	$564K	Sell	8,109 -14,894	-65%	-$608K	﹤0.01%	4607
2025 Q3	$644K	Buy	23,003 +11,404	+98%	+$227K	﹤0.01%	4413
2025 Q2	$241K	Buy	+11,599	New	+$255K	﹤0.01%	4951
2025 Q1	–	Sell	-11,485	Closed	-$311K	–	5426
2024 Q4	$311K	Buy	11,485 +646	+6%	+$22.9K	﹤0.01%	4496
2024 Q3	$476K	Sell	10,839 -497	-4%	-$19.2K	﹤0.01%	4036
2024 Q2	$445K	Buy	11,336 +2,542	+29%	+$104K	﹤0.01%	3964
2024 Q1	$377K	Buy	+8,794	New	+$371K	﹤0.01%	4019

Other funds holding GPCR

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Pacific Heights Asset Management San Francisco, California $3.1B AUM 37.54% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

SEB Asset Management Stockholm $27B AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

DCF Advisers Greenwich, Connecticut $444M AUM 151.5% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

TrueMark Investments Chicago, Illinois $856M AUM 21.72% 1-Year Est. Return

LPL Financial's GPCR Position: Q3 2026 in Review

LPL Financial increased its Structure Therapeutics (GPCR) stake by 30% in Q3 2026, buying an estimated $203K and bringing the position to 18,667 shares worth $584K. The position accounts for ﹤0.01% of the portfolio, ranked #4985.

LPL Financial first reported a position in GPCR in Q1 2024 and has held it in 10 quarters since. The position peaked at $769K in Q2 2026. 49 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.

LPL Financial held 18,667 shares of Structure Therapeutics worth $584K as of Q3 2026.
LPL Financial bought 4,334 Structure Therapeutics shares in Q3 2026, an estimated $203K.
Structure Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #4985 holding.
LPL Financial first reported a position in Structure Therapeutics in Q1 2024 and has held it in 10 quarters since.
LPL Financial's Structure Therapeutics position peaked at $769K in Q2 2026.
49 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.